X-153905169-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP7BS2

The NM_000054.7(AVPR2):​c.24C>T​(p.Ser8Ser) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000014 in 1,210,664 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 1 hem., cov: 25)
Exomes 𝑓: 0.000013 ( 0 hom. 4 hem. )

Consequence

AVPR2
NM_000054.7 splice_region, synonymous

Scores

2
Splicing: ADA: 0.00005683
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -9.59

Publications

0 publications found
Variant links:
Genes affected
AVPR2 (HGNC:897): (arginine vasopressin receptor 2) This gene encodes the vasopressin receptor, type 2, also known as the V2 receptor, which belongs to the seven-transmembrane-domain G protein-coupled receptor (GPCR) superfamily, and couples to Gs thus stimulating adenylate cyclase. The subfamily that includes the V2 receptor, the V1a and V1b vasopressin receptors, the oxytocin receptor, and isotocin and mesotocin receptors in non-mammals, is well conserved, though several members signal via other G proteins. All bind similar cyclic nonapeptide hormones. The V2 receptor is expressed in the kidney tubule, predominantly in the distal convoluted tubule and collecting ducts, where its primary property is to respond to the pituitary hormone arginine vasopressin (AVP) by stimulating mechanisms that concentrate the urine and maintain water homeostasis in the organism. When the function of this gene is lost, the disease Nephrogenic Diabetes Insipidus (NDI) results. The V2 receptor is also expressed outside the kidney although its tissue localization is uncertain. When these 'extrarenal receptors' are stimulated by infusion of a V2 selective agonist (dDAVP), a variety of clotting factors are released into the bloodstream. The physiologic importance of this property is not known - its absence does not appear to be detrimental in NDI patients. The gene expression has also been described in fetal lung tissue and lung cancer associated with alternative splicing. [provided by RefSeq, Jul 2008]
AVPR2 Gene-Disease associations (from GenCC):
  • diabetes insipidus, nephrogenic, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nephrogenic syndrome of inappropriate antidiuresis
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • nephrogenic diabetes insipidus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP7
Synonymous conserved (PhyloP=-9.59 with no splicing effect.
BS2
High AC in GnomAdExome4 at 14 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AVPR2NM_000054.7 linkc.24C>T p.Ser8Ser splice_region_variant, synonymous_variant Exon 2 of 4 ENST00000646375.2 NP_000045.1 P30518-1
AVPR2NM_001146151.3 linkc.24C>T p.Ser8Ser splice_region_variant, synonymous_variant Exon 2 of 3 NP_001139623.1 P30518-2
AVPR2NR_027419.2 linkn.464C>T splice_region_variant, non_coding_transcript_exon_variant Exon 2 of 4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AVPR2ENST00000646375.2 linkc.24C>T p.Ser8Ser splice_region_variant, synonymous_variant Exon 2 of 4 NM_000054.7 ENSP00000496396.1 P30518-1
ENSG00000284987ENST00000646191.1 linkn.96+3901G>A intron_variant Intron 1 of 4 ENSP00000493873.1 A0A2R8Y4P6

Frequencies

GnomAD3 genomes
AF:
0.0000355
AC:
4
AN:
112591
Hom.:
0
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.0000646
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000930
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000281
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000273
AC:
5
AN:
183023
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.000152
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000123
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000128
AC:
14
AN:
1098020
Hom.:
0
Cov.:
32
AF XY:
0.0000110
AC XY:
4
AN XY:
363456
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26396
American (AMR)
AF:
0.0000568
AC:
2
AN:
35198
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19381
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54141
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40527
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4101
European-Non Finnish (NFE)
AF:
0.0000107
AC:
9
AN:
841994
Other (OTH)
AF:
0.0000434
AC:
2
AN:
46077
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000266
AC:
3
AN:
112644
Hom.:
0
Cov.:
25
AF XY:
0.0000287
AC XY:
1
AN XY:
34810
show subpopulations
African (AFR)
AF:
0.0000322
AC:
1
AN:
31044
American (AMR)
AF:
0.0000929
AC:
1
AN:
10762
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.000282
AC:
1
AN:
3550
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2733
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6283
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53191
Other (OTH)
AF:
0.00
AC:
0
AN:
1523
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000480
Hom.:
0
Bravo
AF:
0.0000189

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jul 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change affects codon 8 of the AVPR2 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the AVPR2 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs201419746, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with AVPR2-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.0010
DANN
Benign
0.83
PhyloP100
-9.6
PromoterAI
-0.095
Neutral
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000057
dbscSNV1_RF
Benign
0.056
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201419746; hg19: chrX-153170623; COSMIC: COSV61686024; COSMIC: COSV61686024; API